Publication

Article

June 2, 2014

Cardiology Review® Online

June 2014

Volume30

Issue 3

CME Test

Articles in this issue

CME Instructions

Cardiology Review Editorial Advisory Board

Transitioning to Summer With Cardiology Review

What Your Patients Are Reading

American Society of Hypertension 2014 Annual Scientific Meeting

Mitral Valve Repair vs Replacement for Severe Ischemic Mitral Regurgitation

Red Blood Cell Transfusion in Patients Undergoing PCI

Reconsidering Digoxin in Worsening Chronic Heart Failure

Safety and Efficacy of Drug-Eluting Stents in Women

Does Anger Predict a Higher Likelihood of Cardiovascular Events?

The ACA Debate: Does It Belong in the Courts or Congress?

Addressing Childhood Obesity in the United States

Related Videos

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Stephen Nicholls, MBBS, PhD | Credit: Monash University

Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology

Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University

Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital

Viet Le, DMSc, PA-C | Credit: APAC

Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM | Image Credit: Radcliffe Cardiology

Orly Vardeny, PharmD | Credit: JACC Journals

Christian T. Ruff, MD, MPH: Abelacimab Cuts Bleeding Risk Versus Rivaroxaban| Image Credit: Brigham & Women's Hospital

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.